How long a cat lives with cancer depends heavily on the type of cancer, how early it’s caught, and whether treatment is pursued. Some cats survive several years with slow-growing tumors, while aggressive cancers can be fatal within weeks if untreated. The most common feline cancers have median survival times ranging from about six weeks to over three years, so there is no single answer.
Understanding where your cat’s diagnosis falls on that spectrum can help you make informed decisions about treatment, comfort care, and what to expect in the months ahead.
Survival Times by Cancer Type
The type of cancer matters more than almost any other factor. Here’s what the data shows for the most common feline cancers:
- Lymphoma (large cell, gastrointestinal): With a standard multi-drug chemotherapy protocol, 50% to 75% of cats respond to treatment, and median survival is 6 to 9 months. Some cats live a year or longer. Without treatment, large cell lymphoma can be rapidly fatal, often within weeks. Even with chemotherapy, lymphoma is generally not considered curable in cats.
- Oral squamous cell carcinoma: This is one of the most aggressive feline cancers. The overall median survival is just 44 days, and only about 9.5% of cats survive to one year. Palliative treatments like anti-inflammatory medications can offer a modest survival advantage, but the prognosis remains poor regardless of approach.
- Mammary tumors: Tumor size at diagnosis is the strongest predictor. Cats with tumors smaller than 2 cm have a median survival exceeding 3 years. Tumors between 2 and 3 cm drop to around 2 years. Tumors larger than 3 cm carry a median survival of 6 to 12 months. About 85% of feline mammary tumors are malignant, making early detection critical.
- Osteosarcoma (bone cancer): Cats treated with limb amputation have a median survival of about 527 days, roughly a year and a half. Cats generally adapt well to three-legged life, and the survival outlook for feline osteosarcoma is notably better than it is for dogs with the same cancer.
- Splenic mast cell tumors: Cats that undergo surgical removal of the spleen survive a median of 856 days, close to two and a half years. Without surgery, median survival drops to about 342 days. Adding chemotherapy after surgery does not appear to significantly extend survival beyond surgery alone.
- Injection site sarcomas: These tumors, which can develop at vaccination or injection sites, require aggressive surgery with wide margins. When the surgery is radical enough, median survival ranges from about 480 to 901 days (roughly 16 months to 2.5 years), depending on the completeness of tumor removal.
Treatment vs. No Treatment
For most feline cancers, some form of treatment extends life meaningfully compared to no intervention. The gap is especially stark with lymphoma, where untreated cats may survive only a few weeks while treated cats often reach six months or more. Splenic mast cell tumors show a similar pattern: surgery more than doubles median survival time.
Chemotherapy in cats tends to be better tolerated than many owners expect. Cats experience fewer and milder side effects than humans do, and most maintain a normal routine during treatment. A typical chemotherapy course runs three to six months, with individual doses costing $100 to $300. Total costs can reach or exceed $5,000, which is a real factor for many families weighing their options.
When full treatment isn’t pursued, palliative care with oral steroids can help extend quality of life for a few weeks to months with aggressive cancers. This approach focuses on comfort rather than remission, reducing inflammation and sometimes temporarily shrinking tumors enough to relieve symptoms like pain or difficulty eating.
Why Early Detection Changes the Outlook
The mammary tumor data illustrates this most clearly. A cat diagnosed when the lump is still small, under 2 cm, has six times the survival of a cat whose tumor has grown past 3 cm. That’s the difference between years of life and months.
Regular physical exams, both at the vet and at home, give you the best chance of catching tumors early. Lumps along the belly (mammary tumors), swelling in the mouth or jaw (oral cancers), persistent weight loss, changes in appetite, and unexplained vomiting or diarrhea are all worth investigating promptly. Many of these cancers become significantly harder to treat once they’ve grown or spread.
Measuring Your Cat’s Quality of Life
Survival time in months doesn’t capture the full picture. A cat that lives eight months with energy, appetite, and interest in its surroundings is in a very different situation from one that lives eight months in visible discomfort. Veterinary oncologist Alice Villalobos developed a widely used framework to help owners assess quality of life across seven areas: pain control, appetite, hydration, hygiene, happiness, mobility, and whether the cat has more good days than bad.
Pain is the most important factor. If your cat’s pain can be managed effectively, the other areas become easier to support. Happiness means watching for whether your cat still shows interest in family activity, responds to affection, or engages with its environment. A cat that withdraws, stops grooming, or seems persistently anxious or fearful is telling you something important.
The “more good days than bad” criterion is the one most owners eventually rely on. Tracking this day by day, even with a simple calendar notation, helps you see trends rather than reacting to a single rough afternoon. When bad days begin to consistently outnumber good ones, most veterinarians and owners agree that the balance has shifted.
What Affects Survival Beyond Cancer Type
Several factors influence where within a survival range your cat is likely to fall. The stage of cancer at diagnosis is one of the biggest. Cancers that have already spread to lymph nodes or other organs carry shorter survival times than localized tumors, regardless of type.
Your cat’s overall health and age matter too. A younger cat with no other medical conditions is more likely to tolerate surgery or chemotherapy well and to respond favorably. Cats with concurrent kidney disease, hyperthyroidism, or heart conditions may not be candidates for aggressive treatment, which narrows the options.
How the tumor responds to the first round of treatment is also telling. Cats whose cancers shrink significantly with initial chemotherapy tend to have longer remissions. Those that don’t respond to first-line treatment have a less favorable outlook, though second-line options exist for some cancer types. Your veterinarian or veterinary oncologist can give you a clearer picture once they see how your cat responds in the first few weeks of therapy.